DDI2 as novel therapeutic target in Multiple Myeloma treatment
- Project Number: LSC19-012
- Project Lead: Martin Willheim, Karl Landsteiner University of Health Sciences / Institute of Laboratory Medicine (University Hospital St. Pölten)
- Project Partner: IMC University of Applied Sciences Krems
- Duration: 36 months starting from 01.09.2021